Endometriosis (P19-933)

Real-world experience of elagolix for the treatment of endometriosis in Canada: an observational cohort study (GRACE)

Register Today!

Trial Information

Start Date14 November 2019
End DateApril 2020
Trial Duration18 months (12 mo treatment period, 6 mo follow up)
Number of Visits6 in person, 9 monthly diary questionnaires
Lead CRCAdam Pawluch
StatusOngoing Trial

For additional information on this trial contact: